Abstract:Objective Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with high mortality rate, especially SFTS combined with central neurological complications. The purpose of this study was to explore risk factors of central neurological complications in SFTS patients. Methods In this retrospective study, SFTS patients admitted to the First Affiliated Hospital of Nanjing Medical University between January 2017 and December 2021 were enrolled. Based on the presence or absence of central neurological complications, SFTS patients were divided into case group and control group. The patients’ laboratory parameters and clinical data were collected for statistical analysis. Receiver operating characteristic (ROC) curve analysis was used to evaluate the prediction accuracy of independent risk factors in identifying SFTS patients with central neurological complications. Results In total, 198 hospitalized SFTS patients with complete medical records, clear etiological diagnosis and clinical outcomes were enrolled in this study. Of these, 74 (37.4%) cases were diagnosed with SFTS with central neurological complications, 29 (39.2%) cases died, and no death occurred in the control group. Multivariate logistic regression analysis revealed pulmonary rales, atrial fibrillation, and high serum SFTSV RNA, lactate dehydrogenase level during the fever stage as independent risk factors for the development of central neurological complications in SFTS patients. ROC curve analysis showed that the area under the ROC curve (AUC) of serum SFTSV RNA and lactate dehydrogenase levels were 0.748 (95% CI : 0.673–0.823, p < 0.001) and 0.864 (95% CI : 0.815–0.914, p < 0.001), respectively, in central neurological complications predicted in SFTS patients. Conclusion Severe fever with thrombocytopenia syndrome (SFTS) combined with central neurological complications has high morbidity and mortality and diverse clinical manifestations. Early monitoring of lung signs, electrocardiogram, blood SFTSV RNA, and lactate dehydrogenase levels in SFTS patients may be useful in predicting the occurrence of central neurological complications.

Establishment of an Early Prediction Model for Severe Fever With Thrombocytopenia Syndrome‐Associated Encephalitis

Scoring Model for Predicting the Occurrence of Severe Illness in Hospitalized Patients with Severe Fever with Thrombocytopenia Syndrome.

A Scoring Model for Predicting Prognosis of Patients with Severe Fever with Thrombocytopenia Syndrome

Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study

A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients.

Severe Fever with Thrombocytopenia Syndrome Bunyavirus-Related Human Encephalitis

Prediction of prognosis in patients with severe fever with thrombocytopenia syndrome

Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients

A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome.

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with SFTS

Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: A five-year retrospective case–control study

Time series models in prediction of severe fever with thrombocytopenia syndrome cases in Shandong province, China

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome

Risk Factors for Mortality in Severe Fever with Thrombocytopenia Syndrome Patients with Central Nervous System Complications

Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission

A nomogram and heat map based on LASSO‐Cox regression for predicting the risk of early‐stage severe fever with thrombocytopenia syndrome patients developing into critical illness at 7‐day and 14‐day

Clinical Progress and Risk Factors for Death from Severe Fever with Thrombocytopenia Syndrome: A Multihospital Retrospective Investigation in Anhui, China.

Analysis of Severe Fever with Thrombocytopenia Syndrome in Critical Ill Patients in Central China.

Ecological niche modeling for predicting the potential risk areas of severe fever with thrombocytopenia syndrome.

A Nomogram to Predict Mortality in Patients with Severe Fever with Thrombocytopenia Syndrome at the Early Stage—a Multicenter Study in China